鲁III - - 吗啡衍生型硫化碳基金属药物:色素向的抗癌剂
Monalisa Mohanty1, Sanchita Das1, Pratikshya Das Pattanayak1
1Department of Chemistry, National Institute of Technology, Rourkela, Odisha 769008, India.
ACS applied bio materials
|January 14, 2025
概括
三种新的 (III) 复合物通过选择性地向癌细胞溶解体,显示出强大的抗癌活性. 综合体1表现出最高的细胞毒性,通过活性氧物种生成诱导亡.
科学领域:
- 协调化学 协调化学
- 药用化学 医学化学
- 生物物理化学 生物物理化学
背景情况:
- 越来越多地探索金属中心和生物活性联体的协同效应.
- 西米卡巴配体以其多样化的生物活动而闻名.
研究的目的:
- 为了合成和表征新型的 (((III) 复合物与来自摩尔福林的二氧化碳联体.
- 评估它们的抗癌潜力和对抗癌细胞系的作用机制.
主要方法:
- 使用光谱学和HRMS合成和表征Ru (III) 复合物.
- 单晶X射线衍射用于结构阐明.
- 在体外抗癌活性测定 (细胞毒性,细胞活力).
- 通过吸收,光和循环二元化进行生物分子相互作用研究 (DNA,HSA).
- 活细胞成像用于溶酶体向和ROS生成评估.
主要成果:
- 三个Ru(III) 复合物 (1-3) 已成功合成和表征.
- 复合物表现出溶液稳定性和对HT-29和HeLa细胞的强烈抗癌活性.
- 综合体1显示了最高的细胞毒性.
- 复合物选择性地向溶解体,破坏膜潜力并通过ROS生成诱导亡.
- 观察到与DNA和人血清白蛋白 (HSA) 的有利相互作用.
结论:
- 合成的 (III) 复合物表现出有希望的抗癌特性,对癌细胞具有选择性.
- 溶解体向和ROS介导的亡是其主要的作用机制.
- 复合物1是一种潜在的化合物,可用于进一步开发抗癌药物.
关键词:
它具有抗癌活性,具有抗癌活性.lysosome-targeting 的作用是什么形态质素 (morpholine) 是一种有机物.(III) (III) (III) (III) (III) (III) (III) (III) ) (III) (III) (III) (III) (III) ) (III) (III) (III) (III) (III) (III) (III) (III) (III) ) (III) (III) (III) (III) (III) (III) (III) (III) (III) (III) ) (III) (III) (III) (III) ) (III) (III) (III) (III) (III) (III) (III) ) (III) (III) (III) ) (二) (III) (III) (二) ) (三) (四)这种类型的化基.相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Drugs that Destabilize Microtubules
1.9K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
1.9K
Phase II Reactions: Methylation Reactions
128
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
128
Targets for Drug Action: Overview
6.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.0K
Drug Metabolism: Phase II Reactions
3.6K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
3.6K
Electron Transport Chain: Complex I and II
10.9K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
10.9K


